Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 130

1.

Update on pharmacology of antiplatelets, anticoagulants, and thrombolytics.

Cheng-Ching E, Samaniego EA, Naravetla BR, Zaidat OO, Hussain MS.

Neurology. 2012 Sep 25;79(13 Suppl 1):S68-76. Review.

PMID:
23008416
2.

Future directions in antithrombotic therapy: emphasis on venous thromboembolism.

Axelrod DA, Wakefield TW.

J Am Coll Surg. 2001 May;192(5):641-51. Review. No abstract available.

PMID:
11333101
3.

Multimodal endovascular reperfusion therapies: adjunctive antithrombotic agents in acute stroke.

Lazzaro MA, Zaidat OO.

Neurology. 2012 Feb 14;78(7):501-6. doi: 10.1212/WNL.0b013e318246d6a5. Review.

PMID:
22330414
4.

Current development in antithrombotic therapy.

Mammen EF.

Semin Thromb Hemost. 2004 Dec;30(6):605-7. No abstract available.

PMID:
15630665
5.

[The treatment of acute ischemic stroke].

Csiba L.

Orv Hetil. 2004 Nov 7;145(45):2297-301. Review. Hungarian. No abstract available.

PMID:
15573895
6.

Advances in antithrombotic agents.

Chakrabarti R, Das SK.

Cardiovasc Hematol Agents Med Chem. 2007 Jul;5(3):175-85. Review.

PMID:
17630943
7.

Thrombolytics, anticoagulants, and antiplatelet agents.

Ringleb PA.

Stroke. 2006 Feb;37(2):312-3. Epub 2006 Jan 12. Review. No abstract available.

8.

Guidelines for acute ischemic stroke treatment: part II: stroke treatment.

Martins SC, Freitas GR, Pontes-Neto OM, Pieri A, Moro CH, Jesus PA, Longo A, Evaristo EF, Carvalho JJ, Fernandes JG, Gagliardi RJ, Oliveira-Filho J; Executive Committee from the Brazilian Stroke Society and the Scientific Department in Cerebrovascular Diseases of the Brazilian Academy of Neurology.

Arq Neuropsiquiatr. 2012 Nov;70(11):885-93.

9.

Prior use of antithrombotic agents and neurological functional outcome at discharge in patients with ischemic stroke.

Paciaroni M, Agnelli G, Caso V, Venti M, Alberti A, Milia P, Silvestrelli G, Biagini S.

J Thromb Haemost. 2006 Sep;4(9):1957-61.

10.

Does current oral antiplatelet agent or subtherapeutic anticoagulation use have an effect on tissue-plasminogen-activator-mediated recanalization rate in patients with acute ischemic stroke?

Ibrahim MM, Sebastian J, Hussain M, Al-Hussain F, Uchino K, Molina C, Khan K, Demchuk AM, Alexandrov AV, Saqqur M; CLOTBUST Investigators.

Cerebrovasc Dis. 2010;30(5):508-13. doi: 10.1159/000319029. Epub 2010 Sep 22.

PMID:
20861622
11.

Antithrombotic and thrombolytic therapy for ischemic stroke.

Albers GW, Amarenco P, Easton JD, Sacco RL, Teal P.

Chest. 2001 Jan;119(1 Suppl):300S-320S. Review. No abstract available.

PMID:
11157656
12.

[New era in thrombolytic therapy for cardiovascular diseases].

Goto S.

Nihon Naika Gakkai Zasshi. 2005 Dec 10;94(12):2635-41. Japanese. No abstract available.

PMID:
16419608
13.

Antithrombotic therapy in acute coronary syndromes.

Sabatine MS, Jang IK.

Acta Cardiol. 1999 Feb;54(1):3-29. Review. No abstract available.

PMID:
10214473
14.

Antithrombotic drugs.

[No authors listed]

Treat Guidel Med Lett. 2011 Oct;9(110):61-6; quiz 2 p following 66. No abstract available.

PMID:
21941228
15.

[Acute ischemic stroke. New approaches to antithrombotic treatment].

Kraft P, Nieswandt B, Stoll G, Kleinschnitz C.

Nervenarzt. 2012 Apr;83(4):435-49. doi: 10.1007/s00115-011-3368-6. Review. German.

PMID:
21901539
16.

Next-generation antithrombotics in ischemic stroke: preclinical perspective on 'bleeding-free antithrombosis'.

Kraft P, De Meyer SF, Kleinschnitz C.

J Cereb Blood Flow Metab. 2012 Oct;32(10):1831-40. doi: 10.1038/jcbfm.2012.108. Epub 2012 Jul 18. Review.

17.

How much do you know about anticoagulant therapy?

Wimberley P, Wiggins N.

Nurs Manage. 2004 Feb;35(2):46-7. Review.

PMID:
14767234
18.

Antithrombotic treatment in the prevention of ischemic stroke.

Emre U, Rantanen K, Tatlisumak T.

Curr Drug Targets. 2007 Jul;8(7):817-23. Review.

PMID:
17630934
19.

Drug therapy of neurovascular disease.

Weinberger J, Terashita D.

Heart Dis. 1999 Jul-Aug;1(3):163-78. Review.

PMID:
11720620
20.

Ancillary approaches to plasminogen activators.

Bavarsad Shahripour R, Alexandrov AV.

Ann N Y Acad Sci. 2012 Sep;1268:113-9. doi: 10.1111/j.1749-6632.2012.06688.x. Review.

PMID:
22994229
Items per page

Supplemental Content

Write to the Help Desk